This inventor holds 6 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Nanyang Technological University. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2026
Title: Innovations of Chuan Fa Liu in Peptide Ligation
Introduction
Chuan Fa Liu is a prominent inventor based in Singapore, known for his significant contributions to the field of peptide ligation. With a total of 6 patents, Liu has developed innovative methods that enhance the efficiency and effectiveness of peptide synthesis.
Latest Patents
One of Liu's latest patents is titled "Methods for enzymatic peptide ligation." This invention relates to a method of ligating a first peptide via its C-terminus to the N-terminus of a second peptide, catalyzed by an asparagine/aspartate (Asx) peptide ligase OaAEPI Cys247Ala. The invention also encompasses methods for preparing dimers, oligomers, or multimers of peptides, as well as techniques for modifying or tagging the surface of target cells using peptides. Additionally, Liu has developed a patent for "Butelase-mediated peptide ligation," which involves forming a specific peptide structure by enzymatically cleaving and ligating peptide fragments. This method has potential applications in vaccines, medicaments, and diagnostic agents.
Career Highlights
Chuan Fa Liu is affiliated with Nanyang Technological University, where he continues to advance research in peptide chemistry. His work has garnered attention for its practical applications in various fields, including medicine and biotechnology.
Collaborations
Liu has collaborated with notable colleagues such as James P Tam and Kien Truc Giang Nguyen, contributing to the advancement of peptide research and innovation.
Conclusion
Chuan Fa Liu's innovative work in peptide ligation showcases his expertise and commitment to advancing scientific knowledge. His patents reflect a significant impact on the field, paving the way for future developments in peptide synthesis and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
